Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer
about
Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindredsFamilial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndromeMolecular models for the tissue specificity of DNA mismatch repair-deficient carcinogenesisDevelopment and validation of a colon cancer risk assessment tool for patients undergoing colonoscopy.Screening for Familial Colorectal Cancer Risk amongst Colonoscopy Patients New to an Open-Access Endoscopy Center.Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized MedicineA risk prediction model for smoking experimentation in Mexican American youth.The association between genetic variants in hMLH1 and hMSH2 and the development of sporadic colorectal cancer in the Danish population.Survey of HNPCC Management Analysis of Responses from 18 International Cancer Centres.Some aspects of molecular diagnostics in Lynch syndrome.Clinical challenges in management of familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer.Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.Genetic counseling and clinical cancer genetics services.Lower gastrointestinal tract cancer predisposition syndromesFamilial colorectal cancer: eleven years of data from a registry program in Switzerland.Hereditary colorectal cancer: risk assessment and management.Predictive models for mutations in mismatch repair genes: implication for genetic counseling in developing countrieshMLH1 promoter methylation and BRAF mutations in high-frequency microsatellite instability colorectal cancers not fulfilling the revised Bethesda guidelines.Comparative effectiveness of next generation genomic sequencing for disease diagnosis: design of a randomized controlled trial in patients with colorectal cancer/polyposis syndromesCurrent clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers.Hereditary cancer risk assessment: essential tools for a better approach.Guidance on gastrointestinal surveillance for hereditary non-polyposis colorectal cancer, familial adenomatous polypolis, juvenile polyposis, and Peutz-Jeghers syndrome.Identification of patients at-risk for Lynch syndrome in a hospital-based colorectal surgery clinic.Methods of molecular analysis: mutation detection in solid tumours.Identification of patients at risk for hereditary colorectal cancerPrevalence of alterations in DNA mismatch repair genes in patients with young-onset colorectal cancer.The inherited genetics of ovarian and endometrial cancer.Review article: genetic testing and counselling for hereditary colorectal cancer.A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.Genetic testing for colon cancer: joint statement of the American College of Medical Genetics and American Society of Human Genetics. Joint Test and Technology Transfer Committee Working Group.How to identify the genetic basis of gastrointestinal and liver diseases?Strategies for screening for hereditary non-polyposis colorectal cancer.Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.Pathogenicity of missense and splice site mutations in hMSH2 and hMLH1 mismatch repair genes: implications for genetic testing.Abnormal oral mucosal light reflectance: a new clinical marker of high risk for colorectal cancerHereditary aspects of colon cancerIdentification of Lynch syndrome: how should we proceed in the 21st century?Pancreatic cancer and a novel MSH2 germline alteration.Clinical and pathological tools for identifying microsatellite instability in colorectal cancer.Tolerance of human MSH2+/- lymphoblastoid cells to the methylating agent temozolomide.
P2860
Q24535557-56250B64-5AFC-44A3-A941-90BA7530530AQ24594612-6FED396E-3B3B-49F2-9D3A-7954F005D937Q25257401-FEF2E973-0657-4231-9517-88CDE2A52189Q30484158-CFC5B182-1BD1-43E6-97AF-83236FB9CCCEQ30485461-30593248-7976-4292-A295-61EC3F2CD96DQ30513982-2690DAF9-362A-4C8A-86E5-F381B7929BA4Q30588859-85E023EA-B3BB-4DBF-960A-D0ABE48C81BEQ33343083-5BD87F88-D3BA-4E84-9842-0996F451D35FQ33721542-470BA2AF-39C9-4AAB-AA43-D613EB67455BQ33722604-8257A942-BCA2-4DC5-B447-A047FB835EEDQ33813997-C5448CAB-2BCE-4295-B871-9EE19C75DC25Q33904639-50368C1B-A7E7-41EF-A707-BE968A64681CQ33915613-A5C8A261-70B6-4E3E-8472-E3150E52DF05Q33920573-DF6C2D52-DB53-4FC8-AB04-DB28516369D7Q33931803-A3851E8B-F883-43AF-BD79-65855E5E9531Q34045183-6DB0B64D-2F7E-4D9F-8D17-CEE2B904C7FAQ34155518-41D4C2D1-CE3D-40DC-AC70-66C190FB0D9AQ34221477-201D9B82-0918-4801-97A2-066280648955Q34243496-1505B3A1-A2FF-4565-B202-69C8A381C285Q34289520-B5B8A0FD-FE4A-4D2B-AF12-37C1DD540DA3Q34507839-2FE85839-1CEF-42ED-9468-649C2F3DC230Q34526950-358E39A8-790C-4826-8B4B-5E55E48E401BQ34591199-C207192F-6468-4122-B40C-DCA447663606Q34598419-A918C4A3-D079-4403-8360-0476E9901F65Q34652530-97D754DB-2DC0-4CD9-927A-BE2E45D3A930Q34677794-749C04A1-654E-4230-873A-91346CB20E55Q34775177-91489173-3149-4803-B93C-C72113B299B8Q34975833-8174E9AB-5351-4013-AAC1-7A2C57EDC961Q35013990-A14FC481-A4F2-48CB-9A5A-6C5338541A91Q35034265-4D01EAD7-22BC-46AD-8B67-7548210FB493Q35090214-480E4F0A-93BC-4C7F-A608-71AA9F229F30Q35431098-BB3589CE-DAEC-4D06-B0CA-09A8DDD39600Q35435690-FE05563C-380A-4F9C-866A-184477B1B0DEQ35594437-CEACC186-A5FF-416F-81FB-7C3365189CC1Q35760885-D76CD0CB-D87E-44FA-AA77-C7F393B250D0Q36101834-92595134-A26B-4D35-BA33-E379A47F1281Q36179036-AD3DF7EC-C757-43E1-BCF0-AB17AAB1B949Q36182997-1021AB14-8DCB-4812-B1FA-5049AAB10F0BQ36193110-AE84B993-F38C-46E5-BC84-A936B73ED9A1Q36296721-02484C32-0E56-4F3A-AE25-5DBD95952A15
P2860
Clinical Findings with Implications for Genetic Testing in Families with Clustering of Colorectal Cancer
description
im August 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 1998
@uk
name
Clinical Findings with Implica ...... lustering of Colorectal Cancer
@en
Clinical Findings with Implica ...... lustering of Colorectal Cancer
@nl
type
label
Clinical Findings with Implica ...... lustering of Colorectal Cancer
@en
Clinical Findings with Implica ...... lustering of Colorectal Cancer
@nl
prefLabel
Clinical Findings with Implica ...... lustering of Colorectal Cancer
@en
Clinical Findings with Implica ...... lustering of Colorectal Cancer
@nl
P2093
P50
P1476
Clinical Findings with Implica ...... lustering of Colorectal Cancer
@en
P2093
Adri Mulder
Aeilko H. Zwinderman
Anne Meijers-Heijboer
Annette Bröcker-Vriends
Carli Tops
Cees Schaap
Egbert Bakker
Fokko Nagengast
Fred Menko
P304
P356
10.1056/NEJM199808203390804
P407
P577
1998-08-20T00:00:00Z